Apr 21

Forget injections. A new drug promises to be just as effective as Ozempic  — but is taken as a daily pill. Called orforglipron, the results of a new clinical trial announced Thursday by manufacturer Eli Lilly suggest that the pill could be a breakthrough in a class of drugs called GLP-1 agonists, which have become … Read more

Researchers link GLP1 agonists to depression risk in some users and call for personalized prescribing based on genetic testing. A study published in Current Neuropharmacology reveals a potential link between Glucagon-like Peptide-1 (GLP-1) receptor agonists, commonly used in drugs like Ozempic, and an increased risk of depression and suicidal ideation (SI). Using advanced pharmacogenomic computational … Read more